Boston Scientific Bids on a Medtronic Foe

Boston Scientific Bids on a Medtronic Foe

Submitted by admin on January 8, 2024 - 10:20pm
Source: 
Medical Devices and Diagnostics Industry
News Tags: 
Medtech
Axonics
Boston Scientific
M&A
urology
sacral neuromodulation
Headline: 
Boston Scientific Bids on a Medtronic Foe
snippet: 
  • The equity value of the deal is about $3.7B and the enterprise value is about $3.4B.
  • The Axonics products are designed to treat urinary and bowel dysfunction.
  • Boston Scientific expects to complete the deal in the first half of 2024.

Do Not Allow Advertisers to Use My Personal information